Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01)

JAMA

Volumn 281, Issue 17, 1999, Pages 1623-1627

  Cooper, Jay S ^a   Guo, Matthew D ^a   Herskovic, Arnold ^a   Macdonald, John S ^a   Martenson, James A ^a   Al Sarraf, Muhyi ^a   Byhardt, Roger ^a   Russell, Anthony H ^a   Beitler, Jonathan J ^a   Spencer, Sharon ^a   Asbell, Sucha O ^a   Graham, Mary V ^a   Leichman, Lawrence L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0033526355     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.17.1623     Document Type: Article

References (19)

1. Harras A, Edwards BK, Blot WJ, Gloecker Ries LA, eds. Cancer Rates and Risks. 4th ed. Washington, DC: US Dept of Health and Human Services, Public Health Service, National Institutes of Health; 1996. NIH publication 96-691.
2. Earlam R, Cuhna-Melo JR. Oesophageal squamous cell carcinoma, I: a critical review of surgery. Br J Surg. 1980;67:381-390.
3. Earlam R, Cuhna-Melo JR. Oesophageal squamous cell carcinoma, II: a critical review of radiotherapy. Br J Surg. 1980;67:457-461.
4. Swisher SC, Hunt KK, Holmes EC, et al. Changes in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg. 1995;169:609-614.
5. Leichman L, Steiger Z, Seydel HG, et al. Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology Group and Radiation Therapy Oncology Group experience. Semin Oncol. 1984;11:178-185.
6. Kelsen DP, Bains M, Hilaris B, et al. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin. Cancer. 1982;49:1174-1177.
7. Leichman L, Berry BT. Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol. 1991;18(suppl3):64-72.
8. Forastiere AA. Treatment of loco-regional esophageal cancer. Semin Oncol. 1992;19(suppl 11):57-63.
9. Al-Sarraf M. The current status of combined modality treatment containing chemotherapy in patients with esophageal cancer, Int J Radiat Oncol Biol Phys. 1990;19:813-815.
10. Poplin F, Fleming T, Leichman L, et al. Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group study (SWOG-8037). J Clin Oncol. 1987;5:622-628.
11. Seydel HG, Leichman L, Byhardt R, et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG study. Int J Radiat Oncol Biol Phys. 1988;14:33-35.
12. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
13. Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15:277-284.
14. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996;276:637-639.
15. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1998;16:1141-1154.
16. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 3:457-481.
17. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
18. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549-556.
19. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.